2020
November 23 – COVID-19 pandemic: AstraZeneca's AZD1222 vaccine, developed in partnership with Oxford University, is shown to be 70% effective in protecting against COVID-19. The efficacy can be raised to 90% if an initial half dose is followed by a full dose a month later, based on interim data.